Akero Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$284
Gross Profit
-1
-1
282
EBITDA
-54,755
-52,352
-54,287
EBIT
-54,756
-52,353
-54,289
Net Income
-55,987
-53,344
-55,186
Net Change In Cash
0
0
284
Free Cash Flow
-57,453
-35,140
-48,627
Cash
310,355
623,854
234,207
Basic Shares
69,160
59,307
55,717

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-29
-260
-100,886
-80,154
EBITDA
-148,631
-111,034
-100,845
-80,137
EBIT
-148,660
-111,294
-100,886
-80,154
Net Income
-151,759
-108,910
-100,736
-79,190
Net Change In Cash
0
0
0
0
Cost of Revenue
99,290
-36,799
122,542
Free Cash Flow
-145,367
-92,517
-79,681
-70,952
Cash
234,207
249,773
150,483
187,242
Basic Shares
52,568
38,984
34,827
31,463

Earnings Calls

Quarter EPS
2024-09-30
-$1.05
2024-06-30
-$0.81
2024-03-31
-$0.90
2023-12-31
-$0.99